Skip to main content
logo
Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
25.02
-0.28 (-1.11%)
At close: Aug 13, 2026, 4:00 PM EDT
25.10
+0.08 (0.32%)
After-hours: Aug 13, 2026, 7:34 PM EDT

Tyra Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,4931,412705596322583
Market Cap Growth
164.88%100.16%18.38%85.12%-44.80%-
Enterprise Value
1,1451,162370.21398.9273.3282.08
Last Close Price
25.0226.2913.9013.857.6014.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.225.452.062.921.251.93
P/TBV Ratio
4.376.052.322.901.240.64

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.020.020.030.010.00
Net Debt / Equity Ratio
-0.98-0.96-0.98-0.96-0.96-1.00
Net Debt / EBITDA Ratio
2.181.893.232.484.242.27
Net Debt / FCF Ratio
3.172.634.763.874.8912.33
Quick Ratio
14.3814.1523.4013.2744.0683.57
Current Ratio
14.9114.6723.8113.8045.1384.09
Return on Equity (ROE)
-48.48%-39.83%-31.60%-29.92%-18.49%-75.98%
Return on Assets (ROA)
-48.19%-41.09%-35.35%-32.50%-20.57%-82.28%
Return on Invested Capital (ROIC)
-929.37%-777.80%-672.70%-669.75%-961.84%-7141.58%
Return on Capital Employed (ROCE)
-51.49%-43.28%-37.24%-33.95%-20.91%-83.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-4.40%-4.17%-33.98%-1.96%-203.94%-793.58%
Total Shareholder Return
-4.40%-4.17%-33.98%-1.96%-203.94%-793.58%
SEC Filings: 10-K · 10-Q